The recent challenges in global distribution have highlighted the importance of securing critical medications like Ivermectin. Relying on overseas producers exposes regions to significant vulnerabilities, including delivery delays, expense fluctuations, and even geopolitical risks. Shifting towards domestic production of Ivermectin offers a multitu